App-Quantinova.ai

Incidence and Clinical Impact of Stent Fracture After the Nobori Biolimus-Eluting Stent Implantation

Masashi Iwabuchi - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Crofelemer

Clinical Outcomes in the Percutaneous Coronary Intervention of In-Stent Restenosis with the XIENCE V Everolimus-Eluting Stent

Michael Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Angiographic localized haziness after drug-coated balloon angioplasty in de-novo lesions does not increase the risk of acute coronary thrombosis

Theresa Weichert - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Clopidogrel bisulfate

Incidence of late thrombosis after paclitaxel-coated balloon angioplasty in de-novo coronary artery disease

Theresa Weichert - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Paclitaxel

Drug-Eluting Balloon in the Treatment of Instent Restenosis and Diffuse Coronary Artery Disease; Real World Experience from a Single Center Registry

Sandeep Basavarajaiah - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The SYNTAX Score And Risk Of Stent Thrombosis In Patients Undergoing PCI For NSTE-ACS: An ACUITY Trial PCI Cohort Analysis

Mayank Yadav - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Long-term Impact of Antiplatelet Therapy Interruption on Stent Thrombosis Following Percutaneous Coronary Intervention with the Resolute Zotarolimus-eluting Stent

Ajay J. Kirtane - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

ZoMaxx

Relation of Stent Thrombosis to Interruption of Dual Antiplatelet Therapy After Resolute Zotarolimus-eluting Stent Implantation

Deepak L Bhatt - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Is Early Stent Thrombosis Reduced in Cobalt-Chromium Everolimus-Eluting Stent in Humans?

Fumiyuki Otsuka - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Is the Prevalence of Stent Fracture in MULTI-LINK VISION Everolimus-Eluting Stents Different from Bare Metal MULTI-LINK VISION Stents?

Fumiyuki Otsuka - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Everolimus

Angiographic and clinical analysis of 164 cases of longitudinal stent deformation: comparison of cases from a multicentre case series with cases identified from the MAUDE database

Nizar Shakhshir - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical characteristics, procedural and clinical outcome of patients treated with PCI for definitive stent thrombosis: a 12 years single centre experience

Eduard Fernandez-Nofrerias - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Effect of different drug-eluting stent design on in-stent restenosis and stent thrombosis

Oskar Angeras - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

ZoMaxx

Predictors of Early Stent Thrombosis After Implantation of Drug-Eluting Stents in Daily Clinical Practice - A Subanalysis of the Large, Prospective DESIRE (Drug-Eluting Stent In the REal World) Registry

Ricardo A. Costa - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Impact of Second Generation Drug-Eluting Stents on the Occurrence of Late and Very Late Stent Thrombosis - A Subanalysis of the Large, Prospective DESIRE (Drug-Eluting Stent In the REal World) Registry

Ricardo A. Costa - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Umirolimus

RENAL ARTERY ANEURYSMS. FIRST HUMAN TREATMENT WITH THE MULTILAYER FLOW MODULATOR

Michel C Henry - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

The Multilayer Flow Modulator Stent for the Treatment of Popliteal Aneurysm.

Michel C. Henry - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

THE MULTILAYER FLOW MODULATOR STENT FOR THE TREATMENT OF THORACO ABDOMINAL AND ABDOMINAL AORTIC ANEURYSMS. MAROCCAN EXPERIENCE

Michel C. Henry - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Long-Term CT-Scan Follow-up Of Inferior Vena Cava Filter: Warning Bells From A Single-Center Experience

Paolo M. Ravagnani - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Catheter directed thrombolysis in deep venous thrombosis with or without pulmonary thromboembolism

Maddury Jyotsna - Transcatheter Cardiovascular Therapeutics (TCT) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Streptase

Filters

7277 Abstracts